TRGC1 and COVID-19: The levels of TCRα/β and TCRγ/δ were decreased both in the moderate/severe COVID-19 and critical COVID-19 groups; however, the levels of both the populations were significantly lower in the ICU COVID-19 patients (both p < 0.001).